dehydroascorbic acid has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harguindey, S; Hart, T; Kelly, D; Poydock, ME; Takita, H | 1 |
1 other study(ies) available for dehydroascorbic acid and Leukemia L 1210
| Article | Year |
|---|---|
Mitogenic inhibition and effect on survival of mice bearing L1210 leukemia using a combination of dehydroascorbic acid and hydroxycobalamin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cells, Cultured; Dehydroascorbic Acid; Drug Evaluation, Preclinical; Female; Hydroxocobalamin; Leukemia L1210; Mice; Mice, Inbred DBA | 1985 |